A prospective trial for avoiding cervical lymph node dissection for thoracic esophageal cancers, based on intra-operative genetic diagnosis of micrometastasis in recurrent laryngeal nerve chain nodes

Journal of Surgical Oncology

Volumn 93, Issue 6, 2006, Pages 477-484

  Miyata, Hiroshi ^a,b   Yano, Masahiko ^a   Doki, Yuichiro ^a   Yasuda, Takushi ^a   Yoshioka, Setsuko ^a   Sugita, Yurika ^a   Takiguchi, Shuji ^a   Fujiwara, Yoshiyuki ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervical lymphadenectomy; Esophageal squamous cell carcinoma; Lymph node micrometastasis; Real time RT PCR

Indexed keywords

ADULT; AGED; ARTICLE; CERVICAL LYMPH NODE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FOLLOW UP; GENETIC ANALYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LARYNGEAL NERVE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; ADJUVANT THERAPY; CLINICAL TRIAL; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; GENETICS; LYMPH NODE; LYMPHADENECTOMY; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NECK; PATHOLOGY; RECURRENT LARYNGEAL NERVE; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENT;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RECURRENCE; RECURRENT LARYNGEAL NERVE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE;

EID: 33646844446     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20453     Document Type: Article

References (26)

1. Kato H, Watanabe H, Tachimori Y, et al.: Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg 1991;51:931-935.
2. Baba M, Aikou T, Yoshinaka H, et al.: Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 1994;219:310-316.
3. Nishimaki T, Tanaka O, Suzuki T, et al.: Clinical implications of cervical lymph node metastasis patterns in thoracic esophageal cancer. Ann Surg 1994;220:775-781.
4. Altorki NK, Skinner DB: Occull cervical nodal metastasis in esophageal cancer: preliminary results of three-field lymphadenectomy. J Thorac Cardiovasc Surg 1997;113:540-544.
5. Lerut T, Coosemans W, Leyn PD, et al.: Reflections on three field lymphadenectomy in carcinoma of the esophagus and gastroesophageal junction. Hepatogastroenterology 1999;46:717-725.
6. Isono K, Sato H, Nakayama K, et al.: Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991;48:411-420.
7. Akiyama H, Tsurumaru M, Udagawa H, et al.: Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994;220:364-372.
8. Nishihira T, Hirayaina K, Mori S: A prospective randomized trial of exteneded cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 1998;175:47-51.
9. Fujitu H, Sueyoshi S, Tanaka T, et al.: Optimal lynphadenectomy for squamous cell carcinoma in the thoracic esophagus: Comparing the short- and long-term outcome among the four types of lymphadenectomy. World J Surg 2003;27:571-579.
10. Shiozaki H, Yano M, Tsujinaka T, et al.: Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer. Dis Esoph 2001;14:191-196.
11. Yoshioka S, Fujiwara Y, Sugita Y, et al.: Real-time rapid reverse transcriptase-polymerase chain reaction for intraoperative diagnosis of lymph node micrometastasis: Clinical application for cervical lymph node dissecton in esophageal cancers. Surgery 2002;131:34-40.
12. Lagergren J, Bergstrom R, Lindgren A, et al.: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;130:883-890.
13. Blot WJ, Devesa SS, Kneller RW, et al.: Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-1289.
14. Devesa SS, Blot WJ, Fraumeni JF, et al.: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-2053.
15. Orringer MB, Marshall B, Stirling MC: Trunshiatal esophagectomy for benign and malignant disease. J Thorac Cardiovasc Surg 1993;105:265-276.
16. Hulscher JB, van Sandick JW, de Boer AG, et al.: Extended transthoracic resection compared with limited transhiatal resection for adenocarsinoma of the esophagus. N Engl J Med 2002;347:1662-1669.
17. Altorki N, Kent M, Ferrara C, et al.: Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002;236:177-183.
18. Igaki H, Tachimori Y, Kato H: Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg 2004;239:483-490.
19. Hiratsuka M, Miyashiro I, Ishikawa O, et al.: Application of sentinel node biopsy to gastric cancer surgery. Surgery 2001;129:335-340.
20. Kitagawa Y, Fujii H, Mukai M, et al.: Intraoperative mapping and sentinel lymph node sampling in esophageal and gastric cancer. Surg Oncol Clin N Am 2002;11:293-304.
21. Izbicki JR, Hosch SB, Pichlmeier U, et al.: Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes patients with completely resected esophageal cancer. N Engl J Med 1997;337:1188-1194.
22. Luketich JD, Kassis ES, Shriver SP, et al.: Detection of micrometastases in histologically negative lymph nodes in esophageal cancer. Ann Thorac Surg 1998;66:1715-1718.
23. Natsugoe S, Muller J, Stein HJ, et al.: Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: Frequency, associated tumor characteristics, and impact on prognosis. Cancer 1998;83:858-866.
24. Glickman JN, Torres C, Wang HH, et al.: The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer 1999;85:769-778.
25. Sato F, Shimada Y, Li Z, et al.: Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma. Br J Surg 2001;88:426-432.
26. Hosch S, Kraus J, Schenemann P, et al.: Malignant potential and cytogenic characteristics of occult disseminated tumor cells in esophageal cancer. Cancer Res 2000;60:6836-6840.